Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Adicionar filtros








Intervalo de ano
1.
An. bras. dermatol ; An. bras. dermatol;95(2): 221-237, Mar.-Apr. 2020. tab, graf
Artigo em Inglês | LILACS, ColecionaSUS | ID: biblio-1130848

RESUMO

Abstract With the development of new cancer therapies, systemic toxicity profile and effects on survival achieved an important improvement. However, a constellation of toxicities has emerged, even more remarkably, cutaneous adverse events. This report, developed by a board of Brazilian experts in oncodermatology, aims to establish a guideline for the dermatological care of oncologic patients. When possible, evidence-based recommendations were made, but in many cases, when strong evidence was not available, a consensus was reached, based on some data supporting therapies combined with personal experiences.


Assuntos
Humanos , Dermatopatias/induzido quimicamente , Efeitos Colaterais e Reações Adversas Relacionados a Medicamentos/etiologia , Neoplasias/tratamento farmacológico , Antineoplásicos/efeitos adversos , Pele/efeitos dos fármacos , Fatores de Risco , Administração Tópica , Neoplasias/complicações
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA